E1R
CAS: 1301211-78-8
Ref. 3D-BCC21178
1mg | Descontinuado | ||
2mg | Descontinuado | ||
5mg | Descontinuado | ||
10mg | Descontinuado | ||
25mg | Descontinuado |
Informação sobre produto
E1R is a novel drug substance with clinical data for the treatment of cancer. It is an allosteric modulator that binds to the ATP-binding site of the enzyme and inhibits its activity. E1R has been shown to be an efficient method for identifying inhibitors of bacterial light signal production and energy consumption, which may be useful for the study of microbial growth. The sensitivity test demonstrates that E1R has antimicrobial effects on a wide range of bacteria, including Gram-positive and Gram-negative bacteria.